Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Viatris Misses Estimates, Cash Flow Up


(NASDAQ:VTRS), a global healthcare company known for its broad portfolio of pharmaceutical products, released its fourth-quarter 2024 results on Feb. 27. Despite achieving substantial debt reduction and strategic advancements, Viatris fell short of analysts' forecasts. The adjusted earnings per share (EPS) stood at $0.54, missing the estimated $0.56, while total revenue reached $3,528 million, trailing the predicted $3,592 million.

Although its internal targets were achieved, the external market expectations were not met, reflecting a quarter with both strategic progress and financial challenges.

Source: Analyst estimates for the quarter provided by FactSet.

Continue reading


Source Fool.com

Viatris Inc. Stock

€13.91
0.240%
Viatris Inc. gained 0.240% compared to yesterday.

Like: 0
Share

Comments